Health News 

Moderna completes filing process for full approval of COVID-19 vaccine

, , , ,
FILE PHOTO: A healthcare worker prepares a syringe with the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the COVID-19 pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File Photo

(Reuters) – Moderna Inc has completed the real-time review process for its application to the U.S. Food and Drug Administration (FDA) seeking full approval for its COVID-19 vaccine in people aged 18 years and above, the company said on Wednesday.

As part of the completed submission, Moderna has requested a priority review designation for its vaccine.

Source: Read Full Article

Related posts:
  1. U.S. Congress panel investigating worker safety at meatpacking firms
  2. U.S. administers 335.5 million doses of COVID-19 vaccines – CDC
  3. U.S. teachers' union shifts stance to back vaccine mandate as COVID surges
  4. U.S. CDC panel recommends use of COVID-19 vaccine boosters in immunocompromised